Sale!

PHOX2A Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The PHOX2A Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test is a specialized genetic analysis that detects mutations in the PHOX2A gene responsible for Congenital Central Hypoventilation Syndrome (CCHS). This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to identify genetic variations that disrupt normal breathing control mechanisms. CCHS is a rare neurological disorder characterized by inadequate breathing during sleep, requiring lifelong monitoring and intervention. The test provides crucial diagnostic information for affected individuals and their families, enabling proper medical management and genetic counseling. Results are typically available within 3-4 weeks from blood or DNA samples. This test is priced at $500 USD (discounted from $700 USD) and is essential for pediatric patients presenting with unexplained breathing difficulties during sleep.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PHOX2A Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test

Comprehensive Genetic Analysis for Breathing Control Disorders

The PHOX2A Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test represents a cutting-edge diagnostic tool for identifying mutations in the PHOX2A gene associated with Congenital Central Hypoventilation Syndrome (CCHS). This rare neurological condition affects the autonomic nervous system’s ability to regulate breathing, particularly during sleep. Our advanced testing methodology provides families and healthcare providers with definitive genetic information crucial for accurate diagnosis and comprehensive management strategies.

What This Test Measures and Detects

This specialized genetic test employs Next-Generation Sequencing (NGS) technology to comprehensively analyze the PHOX2A gene for pathogenic variants. The test specifically identifies:

  • Point mutations, deletions, and insertions in the PHOX2A gene
  • Genetic variations affecting breathing control neural pathways
  • Mutations disrupting autonomic nervous system development
  • Inherited or de novo genetic changes causing CCHS
  • Specific variants associated with disease severity and progression

Who Should Consider This Genetic Test

This test is particularly recommended for individuals presenting with the following symptoms or clinical scenarios:

  • Newborns or infants with unexplained breathing difficulties during sleep
  • Children experiencing recurrent episodes of hypoventilation
  • Patients with autonomic nervous system dysfunction
  • Individuals with family history of CCHS or related breathing disorders
  • Unexplained cyanosis (bluish skin discoloration) during sleep
  • Patients requiring mechanical ventilation support during sleep
  • Individuals with associated neurocristopathies or neural crest disorders

Clinical Benefits of PHOX2A Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out CCHS with high precision
  • Family Planning Guidance: Enables informed reproductive decisions
  • Personalized Treatment: Guides appropriate respiratory support strategies
  • Prognostic Information: Helps predict disease course and complications
  • Early Intervention: Facilitates timely medical management
  • Genetic Counseling: Provides basis for comprehensive family risk assessment

Understanding Your Test Results

Our genetic specialists provide detailed interpretation of your PHOX2A gene analysis:

  • Positive Result: Indicates presence of pathogenic PHOX2A mutation confirming CCHS diagnosis
  • Negative Result: Suggests absence of detectable PHOX2A mutations
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation
  • Carrier Status: Identifies individuals with single copy mutations

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history of the patient undergoing testing
  • Genetic counseling session to document family pedigree
  • Identification of family members affected by similar symptoms
  • Comprehensive medical evaluation by pediatric specialist

Take Action Today

Don’t let uncertainty about breathing control disorders affect your family’s health and wellbeing. Our specialized PHOX2A genetic testing provides the clarity needed for proper diagnosis and management. Contact our genetic specialists today to schedule your comprehensive evaluation.

Call or WhatsApp: +1(267) 388-9828 to book your PHOX2A Gene Central Hypoventilation Syndrome Congenital NGS Genetic DNA Test and take the first step toward definitive diagnosis and personalized care.